Glenmark Pharmaceuticals has informed that it enclosed a media release received from Ichnos Glenmark Innovation (IGI), the alliance between the company and its wholly owned subsidiary Ichnos Sciences Inc.
The above information is a part of company’s filings submitted to BSE.